VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | The potential role of metformin in the treatment of Parkinson’s disease

K. Ray Chaudhuri • 29 May 2020
EAN 2020
Movement Disorders Parkinson's Disease Metformin
Biology Perspectives Treatment

K Ray-Chaudhuri, FRCP (Lond), FRCP (Edin), MD, DSc, King’s College London, London, UK, outlines the possible effects of metformin therapy on motor and non-motor features of diabetic patients with Parkinson’s disease. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from K. Ray Chaudhuri

2:31
Unmet needs in Parkinson's disease
K. Ray Chaudhuri • 29 May 2020
2:30
Wellness and holistic health in Parkinson's disease
K. Ray Chaudhuri • 17 Sep 2022
3:24
Managing the vital 5 of Parkinson's disease
K. Ray Chaudhuri • 27 Jun 2022
1:31
The challenges in disease-modifying therapy development in Parkinson’s disease
K. Ray Chaudhuri • 3 Jul 2023

Related Videos

7:21
Recent developments in cell replacement therapy for Parkinson’s disease
Alfonso Fasano • 19 Oct 2023
5:22
Regenerative medicine-based approaches in Parkinson’s disease
Alfonso Fasano • 19 Oct 2023
1:12
Functional electrical stimulation: beyond stroke
Rosalyn Grabarz • 12 Oct 2023
1:42
The importance of partnerships between healthcare professionals and Parkinson’s disease patients
Alfonso Fasano • 7 Sep 2023
The content of VJNeurology is intended for healthcare professionals